
About Intuitive Surgical
Intuitive Surgical (NASDAQ:ISRG) specializes in the development, manufacture, and marketing of robotic-assisted surgical systems, most notably the da Vinci Surgical System. These advanced platforms are designed to expand a surgeon's capabilities and improve outcomes in minimally invasive surgery. By enabling complex surgery with a minimally invasive approach, Intuitive Surgical aims to make surgery more effective, less invasive, and easier on surgeons and patients alike. Their operations span global markets, where they are committed to innovating in the field of medical robotics to address the evolving needs of healthcare systems worldwide. The company's projects and objectives are continually focused on research and development, aiming to refine their existing technologies, explore new surgical applications, and maintain their commitment to improving patient care through advanced surgical options.
Snapshot
Operations
Products and/or services of Intuitive Surgical
- da Vinci Surgical Systems, robotic-assisted surgery technology for minimally invasive procedures.
- Ion endoluminal system, enabling minimally invasive biopsy in the lung.
- Intuitive Ecosystem, including imaging, advanced instruments, and analytics for surgical efficiency.
- da Vinci Skills Simulator, provides simulation training for surgeons using the da Vinci Surgical System.
- Intuitive Da Vinci Energy, advanced energy devices for precise dissection and secure sealing.
- Extended Use Instruments, offering a range of tools designed for multi-quadrant surgeries.
Intuitive Surgical executive team
- Dr. Gary S. Guthart Ph.D.Executive Chair
- Mr. David J. RosaCEO & Director
- Mr. Jamie E. SamathExecutive VP, CFO, Head of Business Technology & Enterprise Technology Leader
- Mr. Henry L. CharltonExecutive VP and Chief Commercial & Marketing Officer
- Dr. Brian E. Miller Ph.D.Head of Digital & AI Strategy
- Mr. Fredrik WidmanVP, Principal Accounting Officer & Corporate Controller
- Mr. Milind WagleChief Information Officer
- Mr. Daniel P. Connally C.F.A.VP & Head of Investor Relations
- Mr. Gary H. Loeb J.D.Chief Legal & Compliance Officer
- Dr. Christopher R. Carlson Ph.D.Executive Vice President of Research, Corporate Development, Corporate Strategy & Intuitive Ventures